• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An ionic liquid-mesoporous silica blend as a novel adsorbent for the adsorption and recovery of palladium ions, and its applications in continuous flow study and as an industrial catalyst?
  Shivani Sharma,Chia-Ming Wu,Ranjit T. Koodali,N. Rajesh RSC Adv., 2016,6, 26668-26678
• 3. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 4. Achieving high-efficiency purely organic room-temperature phosphorescence materials by boronic ester substitution of phenoxathiine?
  Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

Introduction to 2-Bromo-5-picoline-d3 (CAS No: 1185306-03-9)

2-Bromo-5-picoline-d3, chemically designated as 2-bromo-5-methylpyridine-d3, is a deuterated derivative of 2-bromo-5-methylpyridine. This compound is of significant interest in the field of pharmaceutical and biochemical research due to its unique isotopic labeling, which provides a valuable tool for studying metabolic pathways and molecular interactions. The inclusion of deuterium atoms (D) at specific positions enhances the compound's stability and specificity, making it particularly useful in nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) applications.

The molecular structure of 2-Bromo-5-picoline-d3 consists of a pyridine ring substituted with a bromine atom at the 2-position and a methyl group at the 5-position, with deuterium atoms replacing hydrogen atoms at three specific positions. This isotopic modification not only improves the compound's suitability for NMR studies but also allows researchers to differentiate it from its non-deuterated counterparts, thereby facilitating more accurate and detailed structural elucidation.

In recent years, the demand for labeled compounds in drug discovery and development has surged, driven by the need for high-resolution analytical techniques. 2-Bromo-5-picoline-d3 has emerged as a critical intermediate in synthesizing various pharmacologically active molecules. Its brominated pyridine core is a versatile scaffold that can be further functionalized to produce complex derivatives with potential therapeutic applications. For instance, it has been utilized in the synthesis of kinase inhibitors, which are pivotal in treating cancers and inflammatory diseases.

One of the most compelling aspects of 2-Bromo-5-picoline-d3 is its role in mechanistic studies. By incorporating deuterium atoms, researchers can track the metabolism of drug candidates more effectively. This is particularly important in understanding how drugs are processed in the body, which can lead to the identification of metabolic pathways that may be responsible for drug-drug interactions or side effects. The use of deuterated compounds has become a standard practice in modern drug development, as it provides insights that are not achievable with non-labeled analogs.

The synthesis of 2-Bromo-5-picoline-d3 involves multi-step organic transformations that require precise control over reaction conditions. The bromination step at the 2-position of 5-methylpyridine is particularly critical and must be performed under conditions that ensure high regioselectivity. The subsequent deuteration process further demands expertise in isotopic chemistry to achieve the desired labeling pattern. Advances in catalytic deuteration techniques have made it possible to produce highly enriched deuterated compounds like 2-Bromo-5-picoline-d3 with greater efficiency and purity.

Recent studies have highlighted the utility of 2-Bromo-5-picoline-d3 in fragment-based drug design. Fragment-based approaches rely on identifying small molecule fragments that bind to target proteins with high affinity. These fragments can then be optimized into lead compounds through iterative chemical modifications. The use of labeled fragments allows researchers to monitor binding events more closely using NMR spectroscopy, thereby accelerating the discovery process. For example, 2-Bromo-5-picoline-d3 has been employed to study interactions between pyridine-based fragments and protein kinases, providing valuable data for designing novel inhibitors.

The application of 2-Bromo-5-picoline-d3 extends beyond drug discovery into agrochemical research. Pyridine derivatives are common components in pesticides and herbicides due to their ability to interact with biological targets in pests and weeds. By labeling these compounds with deuterium atoms, researchers can better understand their mode of action and environmental fate. This information is crucial for developing more sustainable agrochemicals that are effective yet environmentally benign.

In conclusion, 2-Bromo-5-picoline-d3 (CAS No: 1185306-03-9) represents a significant advancement in isotopic chemistry and its applications span multiple domains including pharmaceuticals, agrochemicals, and biochemical research. Its unique structure and properties make it an indispensable tool for modern scientists seeking to unravel complex molecular interactions and develop innovative therapeutics. As research methodologies continue to evolve, the importance of labeled compounds like 2-Bromo-5-picoline-d3 is expected to grow even further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)